Global Transcriptomics Market, By Product and Services (Instruments, Consumables, Software, Services), Technology (Microarray, Real Time-PCR (qPCR), Sequencing), Application (Diagnostics and Disease Profiling, Drug Discovery, and Others), End User (Pharmaceutical and Biotechnology Companies, Government Institutes and Academic Centers, Contract Research Organizations (CROs)), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The transcriptomics market is expected to witness market growth at a rate of 9.68% in the forecast period of 2021 to 2028. Data Bridge Market Research report on transcriptomics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the biomedical research is escalating the growth of transcriptomics market.
Transcriptomics can be referred to as the study of entire set of RNA transcripts formed by the genome of any organism. Transcriptomics includes the assortment and exploration of transcriptomes and finds varied applications, mainly in the molecular genetics.
Major factors that are expected to boost the growth of the transcriptomics market in the forecast period are the rise in the need for personalized medicine. Furthermore, the rise in the pharmaceutical and biotechnology research and development expenses and the government investments is further anticipated to propel the growth of the transcriptomics market. Moreover, the rise in the applications of RNA sequencing in the transcriptomics is further estimated to cushion the growth of the transcriptomics market. On the other hand, the rise in the capital investments is further projected to impede the growth of the transcriptomics market in the timeline period.
In addition, the rise in the attention on biomarker discovery and the growing of application of toxic genomics will further provide potential opportunities for the growth in the transcriptomics market in the coming years. However, the lack of trained specialists and dearth of efficient bioinformatics tools might further challenge the growth of the transcriptomics market in the near future.
This transcriptomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on transcriptomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Transcriptomics Market Scope and Market Size
The transcriptomics market is segmented on the basis of product and services, technology, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product and services, the transcriptomics market is segmented into instruments, consumables, software, and services.
- On the basis of technology, the transcriptomics market is segmented into microarray, real time-PCR (qPCR), and sequencing.
- On the basis of application, the transcriptomics market is segmented into diagnostics and disease profiling, drug discovery, and others.
- On the basis of end user, the transcriptomics market is segmented into pharmaceutical and biotechnology companies, government institutes and academic centers, and contract research organizations (CROs).
Transcriptomics Market Country Level Analysis
The transcriptomics market is analysed and market size insights and trends are provided by country, product and services, technology, application and end user as referenced above.
The countries covered in the transcriptomics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the transcriptomics market due to the calculated investments in disease pathology research. Furthermore, the expanded attention on the transcriptomics research and development will further boost the growth of the transcriptomics market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth of the transcriptomics market due to the international collaboration and partnership between Asian research institutes. Moreover, the initiative assessed by the system’s performance and developed a new range of applications for the company’s platform is further anticipated to propel the growth of the transcriptomics market in the region in the coming years.
The country section of the transcriptomics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The transcriptomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transcriptomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transcriptomics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Transcriptomics Market Share Analysis
The transcriptomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to transcriptomics market.
The major players covered in the transcriptomics market report are Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc, Thermo Fisher Scientific, BD, Biological Industries, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Takara Bio Inc., Cytognomix, Edico Genome (subsidiary of Illumina, Inc.), GENERAL ELECTRIC COMPANY, Siemens, QIAGEN, Merck KGaA, Kapa Biosystems, Spatial Transcriptomics, and NanoString Technologies, Inc., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Transcriptomics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.